BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 29669792)

  • 1. Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
    Dean CL; Wade J; Roback JD
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29669792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of rapid diagnostic tests for transfusion infectious screening in Africa: a literature review.
    Pruett CR; Vermeulen M; Zacharias P; Ingram C; Tayou Tagny C; Bloch EM
    Transfus Med Rev; 2015 Jan; 29(1):35-44. PubMed ID: 25447555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges for the maintaining the microbiological safety of the UK blood supply.
    Neuberger J; Brailsford SR; Mallinson G; Murphy MF; Simmonds P
    Clin Med (Lond); 2023 Mar; 23(2):151-156. PubMed ID: 36806203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen reduction and blood transfusion safety in Africa: strengths, limitations and challenges of implementation in low-resource settings.
    Ware AD; Jacquot C; Tobian AAR; Gehrie EA; Ness PM; Bloch EM
    Vox Sang; 2018 Jan; 113(1):3-12. PubMed ID: 29193128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Allain JP; Bianco C; Blajchman MA; Brecher ME; Busch M; Leiby D; Lin L; Stramer S
    Transfus Med Rev; 2005 Apr; 19(2):110-26. PubMed ID: 15852240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in pretransfusion infectious disease testing: ensuring the safety of transfusion therapy.
    Downes KA; Yomtovian R
    Clin Lab Med; 2002 Jun; 22(2):475-90. PubMed ID: 12134472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia.
    Alaidarous M; Choudhary RK; Waly MI; Mir S; Bin Dukhyil A; Banawas SS; Alshehri BM
    J Infect Public Health; 2018; 11(5):702-706. PubMed ID: 29703711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation.
    Godbey EA; Thibodeaux SR
    Semin Hematol; 2019 Oct; 56(4):229-235. PubMed ID: 31836028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen reduction technology: methods, status of clinical trials, and future prospects.
    Corash L
    Curr Hematol Rep; 2003 Nov; 2(6):495-502. PubMed ID: 14561394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood Product (Donor) Noninfectious and Infectious Testing and Modification.
    Sarker T; Katz LM; Bloch EM; Goel R
    Clin Lab Med; 2021 Dec; 41(4):579-598. PubMed ID: 34689966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood transfusion: control of infectious risks].
    Laperche S; Lefrère JJ; Morel P; Pouchol E; Pozzetto B
    Presse Med; 2015 Feb; 44(2):189-99. PubMed ID: 25547992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of bacterial load by predonation sampling.
    Chassaigne M; Vassort-Bruneau C; Allouch P; Audurier A; Boulard G; Grosdhomme F; Noel L; Gulian C; Janus G; Perez P
    Transfus Apher Sci; 2001 Jun; 24(3):253. PubMed ID: 11791699
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogen reduction combined with rapid diagnostic tests to reduce the risk of transfusion-transmitted infections in Uganda.
    Butler EK; McCullough J
    Transfusion; 2018 Apr; 58(4):854-861. PubMed ID: 29405306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiological safety of blood transfusion.
    Barbara JA
    Vox Sang; 1998; 74 Suppl 2():11-3. PubMed ID: 9704421
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion medicine and safety.
    Dodd R; Kurt Roth W; Ashford P; Dax EM; Vyas G
    Biologicals; 2009 Apr; 37(2):62-70. PubMed ID: 19230706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serological screening in donors in Mexico: advances and technology].
    Ayala-De la Cruz S; Flores-Aréchiga A; Llaca-Díaz J; Pérez-Chávez F; Salazar-Montalvo RG; Casillas-Vega N
    Rev Med Inst Mex Seguro Soc; 2019 Apr; 57(1):30-35. PubMed ID: 31071252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
    Lackritz EM
    AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of predonation screening for transfusion transmissible infections using rapid test kits in a hospital-based blood transfusion centre.
    Dosunmu AO; Akinbami AA; Ismail AK; Olaiya MA; Uche EI; Aile IK
    Niger Postgrad Med J; 2017; 24(3):162-167. PubMed ID: 29082905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Transfusion risks: importance of blood surveillance].
    Salamon R; Lawson-Ayayi S; Salmi LR
    Transfus Clin Biol; 1994; 1(5):373-8. PubMed ID: 7812464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.